Pharmaceutical Technology
The FDA requires Eli Lilly to evaluate “unexpected serious” risks associated with Foundayo – some of which have been addressed by the ACHIEVE-4 trial.
Pharmaceutical Technology
The FDA requires Eli Lilly to evaluate "unexpected serious" risks associated with Foundayo - some of which have been addressed by the ACHIEVE-4 trial.
Pharmaceutical Technology
The FDA requires Eli Lilly to evaluate “unexpected serious” risks associated with Foundayo – some of which have been addressed by the ACHIEVE-4 trial.